US STOCKS ON THE MOVE-WhiteHawk, Nvidia, Snowflake
BUZZ-US STOCKS ON THE MOVE-WhiteHawk, Nvidia, Snowflake September 28 (Reuters) - Wall Street was set to open lower on Monday after President Donald Trump rejected an Iranian proposal to end the conflict, leading to a spike in crude prices that rekindled inflation concerns and drove Treasury yields higher. .N
** WhiteHawk Therapeutics Inc WHWK.O:
BUZZ - Gains on entering $1.05 million debt facility nL4N45K0AV
** Space Exploration Technologies Corp SPCX.O:
BUZZ - Bernstein sees Starlink broadband revenue reaching $64 billion by 2031 nL4N45K0J8
** Tesla Inc TSLA.O:
BUZZ - Falls; JP Morgan cuts PT, lowers Q3 delivery estimates nL4N45K0HB
** Roblox Corp RBLX.N:
BUZZ - Jefferies downgrades Roblox to 'underperform'; shares fall 3% nL6N45K0BI
** Newmont Corp NEM.N:
** AngloGold Ashanti PLC AU.N:
** Harmony Gold Mining Co Ltd HMY.N:
** Sibanye Stillwater Ltd SBSW.N:
BUZZ - US-listed gold miners fall as bullion slips nL6N45K0GI
** Hecla Mining Co HL.N:
** Coeur Mining Inc CDE.N:
** Endeavour Silver Corp EXK.N:
** Silvercorp Metals Inc SVM.N:
BUZZ - Silver miners fall on higher oil prices nL6N45K0JK
** Mirum Pharmaceuticals Inc MIRM.O:
BUZZ - Rises on FDA nod for rare bone disorder drug nL6N45K0L6
** Kodiak Sciences Inc KOD.O:
BUZZ - Rises after eye-disease drugs meet trial goals nL4N45K0P4
** MediciNova Inc MNOV.O:
BUZZ - Falls as fatty liver drug misses significance on blood-fat reduction nL4N45K0R6
** Nvidia Corp NVDA.O:
BUZZ - Gains after boosting buyback by $150 billion nL6N45K0MQ
** Snowflake Inc SNOW.N:
BUZZ - Drops on $3.5 bln 0% convertible debt sale plans nL6N45K0MS
** Draganfly Inc DPRO.O:
BUZZ - Rises after $10 mln stock deal with Trump Jr.-backed Unusual Machines, US fund nL6N45K0OR
** Meta Platforms Inc META.O:
BUZZ - Retreats after Muse-driven surge last week nL6N45K0OA
** MongoDB Inc MDB.O:
BUZZ - Slumps as CEO exits after short tenure nL6N45K0PC
(Compiled by Rajarshi Roy and Prakhar Srivastava in Bengaluru)
Recent news on Mirum Pharmaceuticals
See all newsMirum Pharmaceuticals Q3 net product sales surge, outlook raised
Brief: Mirum Pharmaceuticals Announces Positive Results From Cohort 2 Of The Pivotal Progress Study Of Atebrioz™ (Zilurgisertib) In Pediatric Patients Aged 6 To <12 Years With Fibrodysplasia Ossificans Progressiva
Mirum climbs on positive late-stage trial results for liver disease drug
US STOCKS ON THE MOVE-Mirum Pharmaceuticals, Meta, Boeing
U.S. STOCKS ON THE MOVE-Royal Caribbean Cruises, SpaceX